PMID: 28984757 The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients A systematic review and meta-analysis Shu Chen, MS, Miaomiao Tao, MS, Lingqiong Zhao, MS, and Xianquan Zhang, MD∗ Monitoring Editor: Laszlo Geza Boros. Author information Article notes Copyright and License information Disclaimer
Do you know what uterine cancer is? While the term uterine cancer may not be as frequently talked about, you’ve no doubt heard of endometrial cancer, the more common type of this female cancer, according to the Mayo Clinic. This is when cancer forms in the tissues of the lining of the uterus (endometrium). The second…
We may tend to think of our health-care system as a national program. In reality, the states and territories are responsible for delivering health-care services. That means local authorities are in charge of setting up health programs and sometimes opinions vary about what’s the best approach. As a result, cancer screening can differ from one…
What to know before you go to your annual gynecology appointment
Nobody ever really believes they could get a life-threatening illness when they’re young – we all somehow believe we’re invincible in our twenties and thirties, and even beyond. But in reality, that’s not the case. And while we don’t want to spend our lives worrying about something that might never happen, it can certainly pay…
Cervical cancer is often detected through Pap smears; after all, there is a correlation between human papillomavirus (HPV) infections and cervical cancer. But now, a study shows that a new HPV test showed promising results in finding precancerous cervical changes. And, not only that, but the test was more accurate than Pap smears at doing…
When it comes to cervical cancer screening, most women receive a cytology-based Papanicolau (Pap) smear, where cells are scraped from the back of the cervix. However, human papillomavirus (HPV)-based testing may be a more accurate way of testing for cervical cancer, new study results suggest.1 Despite the widespread use of cervical cancer screening with a…
Histologically, CC can be characterized by two different sub-categories i.e. (i) invasive squamous cell carcinomas (ISCC) which are frequent and covers 85–90% of CC cases (ii) adenocarcinomas (ADC) which are relatively rare and comprises only 10–15% cases. The CC develops progression of precancerous lesions; called cervical intraepithelial neoplasia (CIN) grade 1–3 or squamous intraepithelial lesion (SIL).
Every year, 21,000 women in the UK develop a gynaecological cancer. Yet it seems we’re still a nation too shy to speak up, with a fifth of women feeling unable to speak to their GP about their symptoms. This is why women’s charity The Eve Appeal and the beauty industry’s Cosmetic Executive Women (CEW) have…
Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Cervical Cancer at ASCO- New Drug on the Block Soon!